Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients

Author： Roayaie Sasan Sheiner Patricia A. Emre Sukru Guy Steven Schwartz Myron E. Boros Peter Miller Charles M.

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.9, Iss.3-4, 2000-08, pp. : 141-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

OKT3 Therapy in Addition to Tacrolimus Is Associated with Improved Long-Term Function in Patients with Steroid Refractory Renal Allograft Rejection

Nephron Clin Pract, Vol. 103, Iss. 3, 2006-03 ,pp. : c94-c99

Karger

Access to resources Recommend Favorite

Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 118-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Th₁/Th₂ cytokines and ICAM–1 levels post-liver transplant do not predict early rejection

By Granot E. Tarcsafalvi A. Emre S. Sheiner P. Guy S. Schwartz M. E. Boros P. Miller C. M.

Mediators of Inflammation, Vol. 9, Iss. 1, 2000-02 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1371-1382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 768-777

John Wiley & Sons Inc

Access to resources Recommend Favorite